Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization
Abstract
Introduction Since recreational legalization of cannabis in Canada in 2018, self-reported use in New Brunswick (NB) has increased from 15.1% to 20.3%, the largest increase of any province. Current literature on the impact of recreational cannabis legislation in other jurisdictions is conflicting, though retail availability has often been delayed on enactment. Given the immediate availability of cannabis in NB after legalization, we sought to establish the effect this had on post-mortem cannabinoid detection. Furthermore, we wanted to investigate the impact that age, sex, and manner of death had on cannabis use. We also established if there were any increases in commonly detected drugs over the study period. Methods A retrospective chart review was conducted on all adult Coroner's cases with toxicology analysis in NB between January 2014 and May 2020 (n = 3060). Differences in the proportion of cannabinoid-positive samples pre- versus post-legalization in the overall cohort as well as within each demographic parameter were assessed using chi-square tests. The effects of demographic parameters on cannabis presence were further assessed by logistic regression. Lastly, chi-square tests for trend were performed to identify increasing trends in cannabis detection, as well as cocaine, ethanol, opiates/opioids, benzodiazepines, and amphetamines over the study period. Results After controlling for age, sex, and manner of death, participants that died after recreational legalization had higher odds of having cannabis present post-mortem than those that died pre-legalization. In addition, demographic sub-analysis identified a greater proportion of cannabinoid-positive samples post-legalization in 25- to 44-year-olds and in deaths classified as either suicide or accidental compared to pre-legalization. We also observed a significant increase in the presence of cocaine and amphetamines in post-mortem samples over the study period. Conclusion This study demonstrates that cannabis use has increased post-legalization in NB, particularly within young adults and those dying by suicide or accidental means. It also highlights the need for future research into the impact that legalization has on cannabis use in other jurisdictions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The increase in cannabinoid-positive post-mortem cases was only significant in the 25-44-year age group.
“The increase in cannabinoid‐positive cases was only significant in the 25–44‐year age group.”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [13]
There were greater proportions of cannabinoid-positive samples after legalization in deaths judged to be suicidal (18.1-30.7%) or accidental (25.8-36.1%).
“There were greater proportions of cannabinoid‐positive samples after legalization in deaths that were judged to be suicidal (18.1–30.7%) or accidental (25.8–36.1%).”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [13]
Decedents after cannabis legalization (21%) were more likely to have cannabis present post-mortem than those who died before legalization (17%).
“They found that decedents after cannabis legalization (21%) were more likely to have cannabis present post‐mortem than those who died before legalization (17% present).”
From The implementation and public health impacts of cannabis legalization in Canada: a systematic review (2023) · cites this paper as [13]
Cites
Risk environments and drug harms: a social science for harm reduction approach
Rhodes, T. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2008.10.003 · Cited by 948 · see citing works
Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30208-5 · Cited by 377 · see citing works
Smart, R., & Pacula, R. L. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669626 · Cited by 305 · see citing works
A literature review and meta-analyses of cannabis use and suicidality
Borges, G., Bagge, C. L., & Orozco, R. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.007 · Cited by 214 · see citing works
Wen, H., Hockenberry, J. M., & Druss, B. G. (2019) · Prevention Science · doi:10.1007/s11121-018-0903-8 · Cited by 107 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Farrelly, K. N., Wardell, J. D., Marsden, E., Scarfe, M. L., Najdzionek, P., Turna, J., & MacKillop, J. (2023) · Substance Abuse Research and Treatment · doi:10.1177/11782218231172054 · Cited by 148 · see citing works
The implementation and public health impacts of cannabis legalization in Canada: a systematic review
Hall, W., Stjepanović, D., Dawson, D., & Leung, J. (2023) · Addiction · doi:10.1111/add.16274 · Cited by 112 · see citing works
“For example, increased cannabis-related presentations may have been associated with increased testing and reporting [12,13].”
Background
- Authors
- Jordan, A., Sherazi, A., Flewelling, A. J., Northrup, V., Naseemuddin, A., & Shea, J. L.
- Affiliations
- Dalhousie University (CA)
- Saint John Regional Hospital (CA)
- Corresponding author
- Shea, Jennifer L.
- Venue
- International Journal of Drug Policy
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 103
- Pages
- 103629
- ISSN
- 0955-3959 (ISSN-L)
- OpenAlex
- W4214648840
- Cited by
- 5
- References
- 5
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Journal of Drug Policy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Autopsy Techniques and Outcomes
- Keywords
- recreational cannabis legalization, cannabinoids, postmortem toxicology, cannabis use trends, suicide, accidental death, young adults, cocaine, amphetamine, New Brunswick
- MeSH terms
- Analgesics, Analgesics, Opioid, Cannabinoids, Cannabis, Cocaine, Hallucinogens, Humans, Legislation, Drug, New Brunswick, Retrospective Studies, Young Adult, Cannabinoid Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review